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1. Introduction
Heterotopic ossification is defined as the formation of bone within soft tissues, most frequently
muscle tissue. The heterotopic ossification of muscles, ligaments and tendons is a potential
complication following trauma, elective orthopaedic surgery, severe burns and neurological
injury. It should not be confused with metastatic calcification associated to hypercalcaemia or
dystrophic calcification related to tumours. Although there is an uncommon hereditary
disease, called fibrodysplasia ossificans progressiva, most cases result from a local trauma
(major local surgery, muscular trauma, fractures) or a neurological injury. The first description
of heterotopic ossification after neurological injury was by Dejerne and Ceillier [1] in 1918, in
soldiers with spinal cord injuries during World War I. Fifty years later, Roberts [2] described
heterotopic ossifications in the elbow after brain injury. Since these articles, several studies
have been published to provide information about causes, diagnosis and treatment of this
complex entity.
This chapter is meant to serve as a review and an update on the literature regarding aetiology,
diagnosis and management of this severe complication after a traumatic brain injury.
2. Epidemiology, aetiology and risk factors
The true incidence rate following neurological injury is difficult to establish clearly. After
spinal cord injury, the percentage varies between 16% and 53% [3-6], and after traumatic brain
injury has been reported to vary between 11% and 22% [7, 8]. A genetic predisposition has
been suggested due to the relationship between neurogenic heterotopic ossifications (NHO)
and fibrodysplasia (or myositis) ossificans progressiva [8]. The preferred locations in both
cases are the proximal limbs and axial musculature. Moreover, a local trauma could predispose
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an individual to developing a bony formation. The influence of an association between human
leukocyte antigens (HLA) and NHO is not clear. Some authors suggest a high prevalence of
HLA-B18 and HLA-B27 in patients with heterotopic ossifications, but these findings should
be confirmed [9].
It has been suggested that there is a higher prevalence in younger patients (20-30 years old),
which may be because neurological injuries are most frequent in this patients [10, 11]. The
incidence rate in relation to gender varies in the literature and the relationship has not been
shown clearly.
The development of bone in soft tissues in orthopaedic surgery is a well-known complication.
This complication has been associated with total hip arthroplasty, fractures or joint dislocations
(mainly in the acetabulum or the elbow) and muscular trauma. For this reason, a relationship
seems to exist between local trauma and the development of heterotopic ossifications.
Although the presence of traumatic brain injury alone could be associated with the develop‐
ment of heterotopic bone, it is not an established predictor. Brain trauma is a constant cause
but there are specific risk factors implicated, such as spasticity, diffuse axonal injury, descere‐
brate posture, respiratory ventilation or prolonged immobilization. In a study of patients with
NHO after traumatic brain injury, Garland [11] showed that 89% of joints were in spastic limbs.
Moreover, diffuse axonal injury seems to be more related than focal brain injury [12]. Therefore,
the extent of neurological damage must be taken into account, due to the fact that the risk is
correlated with the severity of the brain injury. Flin et al. [13] evaluated patients who suffered
from comas after traumatic brain injury in an acute rehabilitation unit. They founded that
decerabrate posture could predispose an individual to NHO.
Ectopic bone after a neurological injury could develop spontaneously, but there is a higher risk
if a local trauma is involved [14]. In general, prolonged immobility during patients’ illnesses,
such as multiple fractures, burn injuries or a coma, may contribute to the formation of hetero‐
topic ossifications. In patients with brain injuries, a relatively long period of immobilization is
frequent and there is therefore an association with the formation of ectopic bone [15].
3. Pathophysiology
Early in the formation of HO, oedema with exudative infiltrate is present, followed by
fibroblastic proliferation and immature connective tissue formation. Posteriorly, osteoid
formation is seen with the subsequent deposition of bone matrix. Primitive osteoid is deposited
as small masses in the periphery early (within the first two weeks) and osteoblasts are noted,
located irregularly. Osteoblasts produce tropocollagen, which polymerizes to form collagen
and secrete alkaline phosphatase, which allows calcium to precipitate and the mineralization
of bone matrix. As mineralization progresses, amorphous calcium phosphate is progressively
replaced by hydroxyapatite crystals. During the following weeks, the lesion matures with a
centripetal pattern, and after 6-12 months an appearance of true bone is noted. The new bone
is always extra-articular and can be contiguous with the skeleton but generally does not involve
the periosteum [16].
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Many hypotheses about the physiopathology of neurogenic myositis ossificans have been
proposed. Different authors have suggested vasomotor and metabolic disorders induced by
immobility, the venous stasis or the induction of enchondral ossification from muscular
microtrauma. The cellular mechanism of heterotopic ossification remains unclear. It has been
postulated that three conditions must be met to achieve heterotopic bone formation [10]: a
stimulating event, oestrogenic precursor cells and a proper environment.
Mesenchymal stem cells are pluripotent progenitor cells with the ability to generate cartilage,
muscle, tendon, fat and bone. These cells are ubiquitous in soft tissues and may be induced to
differentiate into oestrogenic stem cells capable of producing osteoid. Although they play a
key role, these cells alone cannot produce ossification and stimulating factors are necessary.
Growth factors, such as bone morphogenetic protein, could cause the differentiation of
mesenchymal stem cells in a correct environment. Overexpression of bone morphogenetic
protein-4 (BMP-4) has been shown to occur in fibrous dysplasia ossificans progressiva, a
genetic form of heterotopic ossification mentioned before [17]. Related to this, inhibition of
BMP-4 has shown to prevent ossifications in three separate experimental models [18]. Other
stimulating factors such as inteleukin-1, growth hormone, prolactin, prostaglandin E-2, basic
fibroblast growth factor and insulin-like growth factor type-1 have been recognized in the
formation of ectopic bone after neurological injury [19-21]. After a brain injury, it has been
suggested that circulating factors in the blood stimulate heterotopic ossification, but the
specific mechanism remains unclear [22-23].
As has been mentioned before, the local environment has been shown to be important.
Angiogenesis plays a role through the release of angiogenesis factors and differentiation of
pericytes into osteoprogenitor cells [24]. Urist et al. [19] discovered that demineralized bone
matrix could cause bone formation in vascular tissue. Otherwise, when they cultured this
substance in an avascular system they found the development of cartilage. Other contributing
factors in the local environment include hypercalcaemia, tissue hypoxia, pH changes (alkalo‐
sis) or prolonged immobilization.
It has also been suggested that there is a relationship between the nervous system and bone
metabolism. Several neuropeptides and neurotransmitters have been found in the bone tissue.
Glutamate, substance P, leptin, vasoactive intestinal peptide (VIP) and catecholamines have
been shown to modify osteoblastic and osteoclastic activity [25-27].
In summary, there is an interaction of systemic and local factors on mesenchymal stem cells
resulting in their differentiation into osteoblasts and the formation of heterotopic ossification.
4. Location
In patients who have suffered from a spinal injury, NHO develops in sites distal to the level
of the spinal cord damage. After a traumatic brain injury, a considerable percentage of patients
(between 10% and 20%) could develop ossifications around different joints. In all joints, the
development of NHO is typically extra-articular and occurs in the connective tissue between
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the muscle planes and not within the muscle itself [28]. Clinically, an NHO is defined by a
limited decreased range of movement, usually accompanied with pain.
Although upper and lower extremities could be affected, the most commonly affected joint is
the hip. In these patients, the most common location is inferomedial and it seems to be a role
of adductor spasticity. The ossified tissues extend from the pubic symphysis to the medial or
anteromedial femoral shaft and usually the femoral neurovascular bundle lies anteriorly.
Other locations around the hip are the posterior part and the anterior aspect of the joint, below
the anterior superior iliac spine [11]. When the location is posterior, the sciatic nerve could be
involved and if the ossification develops anteriorly it may involve the femoral neurovascular
structure. Gartland et al. have suggested that the anteromedial location is most frequent after
spinal cord injury, whereas inferomedial, lateral and posterior planes are usually affected after
brain injuries [11, 29].
The next most common sites of involvement in patients with traumatic brain injuries are the
shoulders and elbows, with the knees rarely being affected. Nevertheless, knees are frequently
involved in patients with spinal cord injuries. After a head injury, the ectopic bone about the
elbow usually develops posteriorly from the humerus to the olecranon, and could cause
ankylosis of this joint. The ulnar nerve could be affected, due to its close location [30]. Although
the knee is a common location after a spinal cord injury, it is uncommon in patients with brain
damage. In this case, the ectopic bone may occur in any plane, but the inferomedial aspect of
the distal femur seems to be the most frequent [29, 30].
5. Diagnosis
5.1. Clinical presentation
The mean time from injury to development of HO is two or three months, but some studies
have reported numbers from two weeks up to one year [31]. Thorough physical examination
should be performed because this is a critical point for obtaining an early diagnosis. The onset
of a heterotopic ossification may simulate an infection with erythema, warmth and swelling.
Lower limb swelling may mimic deep venous thrombosis (DVT), so this entity should be ruled
out. Differentiating early heterotopic ossification from lower extremity DVT is sometimes
difficult, because the two entities have similar clinical presentation. Furthermore, they also can
occur at the same time due to the mass effect of the ectopic bone, inciting venous compression
and finally phlebitis and thrombus development.
When the passive mobility is examined there is a decreased range of motion. The examiner
may identify a painful joint if the patient is conscious, but the findings described before should
be checked, especially if the patient is in a coma.
Although there is no total agreement, accelerated bone healing has been reported [32]. In
patients with brain injuries, it could be more callus formation but there is a different histolog‐
ical pattern. For this reason, some authors have suggested that this new bone may be a
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heterotopic ossification, because its maturation is performed from the periphery. Callus
maturation after a fracture occurs from the central area [33].
5.2. Laboratory tests
The serum alkaline phosphatase level reflects osteoblastic activity and is useful for obtaining
an early diagnosis, especially in patients who cannot report pain or for whom a physical
examination is difficult. This marker begins to rise two or three weeks after the brain injury,
and values return to normal at approximately four months [34]. A clinical judgement of this
test should be done, because liver disease or associated fractures also could increase the levels.
Furthermore, alkaline phosphatase titres do not correlate with peak activity or maturation of
HO, so they cannot be used to get information about the evolution of the ectopic bone [35].
Nevertheless, this is a cheap and easy screening tool to detect early HO and begin with
treatment. Garland (ref de libro) recommends initiating medical prophylaxis on the basis of
serum alkaline phosphatase elevation if there are no fractures associated.
In a study of patients after acute spinal cord injury, the 24-hour urinary excretion of prosta‐
glandin E2 (PGE2) showed an increase until the maturation of the HO [37]. In patients with
brain injuries, it could also be a valuable indicator before the ectopic bone is established.
Indomethacin is a PGE2- blocking agent, which is a useful medication to prevent this [38].
5.3. Radiography
Plain radiographs are an easy and cheap method to recognize a neurogenic heterotopic
ossification but it may take up to six weeks for ossification to be evident. In some cases, the
HO could develop in several months (Figure 1). Anteroposterior (AP) and lateral radiographs
provide enough information to establish the relationship of the HO to the joint, but further
radiological techniques (CT-Scan, MTI) should be performed to get more information on the
anatomy and the condition of the joint. The typical radiographic appearance of the ectopic
bone is a circumferential ossification with a lucent centre [39].
In the hip, the Brooker classification could be useful, which is commonly used to describe the
pattern and extent of ossification around a total hip arthroplasty. The extent of the ectopic bone
correlates with the degree of functional impairment. According to this classification, there are
four types:
• Type I: Islands of bone within the soft tissues.
• Type II: Bone spurs arising from the pelvis or proximal femur with 1cm or less between
adjacent bone surfaces.
• Type III: Bone spurs arising from the pelvis or proximal femur with more than 1cm between
adjacent bone surfaces.
• Type IV: Confluent bone bridging the pelvis and proximal femur with apparent ankylosis
of the hip.
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A recent classification has been introduced by Mavrogenis et al. [40] according to the anatom‐
ical location of neurogenic HO in the hip: type 1, anterior; type 2, posterior; type 3, anterome‐
dial; type 4, circumferential. These authors suggested that this classification provides better
evaluation of the prognosis after surgical excision than the Brooker classification and they
found higher blood loss for patients with anteromedial (type 3) or circumferential (type 4)
neurogenic ossifications. They also showed a higher risk of recurrence in patients with brain
injuries.
5.4. Bone scans
Bone scans or scintigraphy are considered the most sensitive method of providing early
detection of HO, with detection as early as two weeks after the onset of symptoms [39].
Bone scintigraphy using 99mTc-methylene disphosphonate provides imaging in three phases:
Phase I (dynamic blood flow study), Phase II (Static study for blood pool) and Phase III (amount
of radionuclide in bone). The first two phases allow early detection of incipient ossification at
two or three weeks. In Phase III, this test occurs approximately one week later. The level of
activity on delayed bone scans usually peaks at two months and then it decreases progres‐
sively. Scintigraphy activity returns to normal after approximately 12 months, but it may
remain positive even when the ossification has become mature.
5.5. Ultrasonography (US)
This technique has been used in the early diagnosis of HO about the hip joints, showing a
chaotic disruption of the normal structure of the muscle in the first stages [41]. Later, a
peripherally echogenic and centrally hypoechoic finding can be identified. US has the advant‐
age of the possibility of bedside application and it requires no radiation. Ultrasonography is
also a fast and useful tool for diagnosis of DVT, which is associated with patients with spinal
cord injury as we mentioned before. Nevertheless, ultrasonography is a difficult technique,
which depends on the skills of the examiner.
5.6. Magnetic resonance imaging (MRI) and volumetric computed tomography (CT-Scan)
Although bone scans are considered the most sensitive method for early detection of neuro‐
genic HO, magnetic resonance imaging (MRI) suggests changes compatible with ectopic bone
formation, as soon as two days after clinical presentation, especially in the knee [42]. In this
joint, MRI findings are joint effusion, thickening of the intermuscular septa and a “lacy-
pattern” of the muscles vastus lateralis and medialis in fast spin-echo short time inversion-
recovery (STIR) images.
Evaluation with computed tomography (CT) combined with two and three-dimensional
surface reconstructions provides good differentiation and the extent of the ectopic bone.
Moreover, this technique shows the relationship with the joint, determines the mineral density
of the bone and can predict several intra-articular lesions. In a study performed by Carlier et
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al. [43], they compared the density of the HO around the hip with the iliac wing. Bone
mineralisation was classified in four categories: normal (M1), mild demineralisation (M2),
significant demineralisation with risk of fracture (M3) and evanescent bone with a high risk
of fracture (M4). They correlated these features with surgical findings, so this is an important
issue because osteoporosis underlying the ankylosis can lead to fractures, which are a difficult
challenge in these patients.
If surgical treatment is required, a thorough vascular assessment should be done, because there
is a relationship between the HO and surrounding neurovascular structures (femoral bundle
in the hip). Therefore, helical-CT with intravenous contrast or MRI with contrast (Figure 1)
should be one of the requirements of the preoperative assessment in patients undergoing
surgical excision of HO.
6. Treatment and prevention
The prevention of heterotopic ossification is focused on three basic principles: disrupting the
inductive signalling pathways, altering the osteoprogenitor cells or modifying the environ‐
ment. Although some targets are defined in some diseases such as Progressive Osseous
Heteroplasia, the target cell or target tissue in NHO remains unknown [44]. Maintaining joint
motion by treating spasticity and gentle physical therapy is the goal of early treatment. When
a neurogenic heterotopic ossification is suspected, the treatment should start with medical
treatment and when the ectopic bone is established and symptomatic surgical resection should
be considered carefully. In Figure 2, there is an algorithm, which could be useful to diagnose
and treat this entity.
6.1. Physiotherapy and rehabilitation
Prevention should start with early joint mobilisation. Once the diagnosis of early ossifications
is suspected, physical therapy with the help of passive exercises should be done [45]. If the
patient is conscious, physiotherapy should involve an assisted range of movement exercises
with gentle stretch and terminal resistance training. It is crucial to achieve a good range of
motion without generating pain. Although forceful manipulation, even under anaesthesia,
could be beneficial, it is advisable to avoid aggressive range-of-motion exercises because they
carry the risk of causing more bone formation. This may be due to the effect of repetitive
microtrauma to the joint [46].
The treatment of HO by extracorporeal shock wave has been reported. Brissot et al. [47] showed
less pain and better range of motion and walking distance with this treatment. If the patient
is not a suitable candidate for surgical treatment because of medical comorbidities, shock wave
therapy could also be a good alternative [48].
In conclusion, physical therapy aims to preserve movement and good function, avoiding or
decreasing the risk of ankylosis of the joint.
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Figure 1. Neurogenic ossification in the hip in a patient after a traumatic brain injury. A) Radiograph of the left hip six
months after the brain injury. B) Radiograph showing an anteromedial ossification around the hip causing severe an‐
kylosis, 14 months after the initial injury. C) MRI enhanced with contrast showing a close relationship between the
ossification and the deep femoral artery.
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6.2. Medical treatment
Medical treatment aims to prevent the formation of HO following brain injury and to avoid
recurrence if surgical excision is needed. Due to the fact that the development of HO can occur
within one to two months of the initial injury, the prophylaxis should begin relatively early.
Although there is no consensus on which medication should be used and when treatment
should begin, several drugs have successfully been used.
Nonsteroidal anti-inflammatory drugs (NSAIDs)
These drugs have demonstrated good results in preventing heterotopic ossification after total
hip arthroplasty and several studies support their use following traumatic neurological injury
[49-51]. A Cochrane Review of HO formation after hip replacements performed in 2004,
showed the effectiveness of prevention using NSAIDs perioperatively [52]. A direct effect of
NSAIDs on the formation of heterotopic ossification has been described, due to the inhibition
of the differentiation of mesenchymal cells into oestrogenic cells. There is also an indirect effect,
Figure 2. Diagnosis and treatment of neurogenic heterotopic ossifications
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which refers to the inhibition of bone remodelling by suppression of the prostagland unme‐
diated inflammatory response (specifically PGE-2) [38].
Indomethacin has been considered a useful medication for heterotopic ossification prophylaxis
following total hip replacement. In a randomized controlled trial, Banovac et al. [50] showed
a lower incidence of early and late HO in the indomethacin group. This drug prescribed for
three to six weeks in a dose of 75mg/day, within two months of the injury, may reduce the
incidence of heterotopic ossification by two to three times. These same authors performed a
trial to determine the effect of COX-2 selective inhibitor rofecoxib on the prevention of HO
after spinal cord injury [51]. They concluded that there was a 2.5 times lower risk of developing
ectopic bone. COX-2 selective inhibitors could be an attractive option because of less gastro‐
intestinal side effects; however, rofecoxib was taken off the USA market due to elevation of
cardiovascular risk. In addition, celecoxib, another selective COX-2 inhibitor, showed the same
efficacy as indomethacin in the prevention of HO, but in patients with cardiovascular problems
should be used cautiously. Another COX-2 inhibitor, meloxicam, did not reduce the incidence
of ossification after total hip replacement compared to indomethacin [53, 54].
In conclusion, indomethacin remains the gold standard for pharmacological prevention of HO,
because it is a simple and low cost option. Celecoxib could be a reasonable option in patients
without cardiovascular diseases because it has shown good results with fewer gastrointestinal
effects.
Bisphosphonates
Bisphosphonates have also been used in the prevention of HO. Etidronate disodium is a well-
studied bisphosphonate and it seems to be effective for early ossifications [55, 56] and later
phases of this disease. This medication inhibits precipitation of calcium phosphate and blocks
the aggregation and mineralisation of hydroxyapatite crystals. In primary prevention, Banovac
et al. [56] have suggested that the treatment should begin as soon as elevated alkaline phos‐
phatase is diagnosed or positive findings in ultrasonography or bone scans are shown. In
addition, disphosphonates could have long-term effects on prevention when the treatment is
finished.
In spite of these results, some authors do not recommend bisphosphonates routinely, because
additional fractures are often associated with neurological injuries and the use of bisphosph‐
onates could impede fracture healing [57].
6.3. Radiotherapy
Radiotherapy seems to work by preventing the differentiation of mesenchymal cells into
osteoblasts, which could begin the bone formation. This method has been used successfully to
prevent heterotopic ossification after hip replacements [58, 59]. In a prospective, randomized
study of HO after hip arthroplasty, Knelles et al. found that the best results were obtained with
indomethacin and a single irradiation of 7 Gy or four sessions of 3 Gy. These and other authors
have suggested that a single irradiation of 7 Gy should be useful in patients at risk, especially
if administration of indomethacin is contraindicated [60].
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In patients with a traumatic brain injury, radiation therapy may be given as primary (patients
with high risk of developing HO) or secondary prophylaxis (those who have been diagnosed
with HO and need surgical resection). Sautter-Bihl et al. [62] studied prophylaxis with
radiotherapy in 36 patients with spinal cord injuries. These authors used radiotherapy as
primary prophylaxis in 27 patients and as secondary prevention (after surgical resection) in
11 patients. With an average follow-up of 23.6 months, 30 of the 36 patients showed no
progression of HO and improvements in rehabilitation. It has also been suggested that
radiotherapy provides pain relief and decreased serum alkaline phosphatase level in a case
report of a patient with HO in both hips and thighs after a brain injury [63]. In this case, the
symptoms were refractory to indomethacin, so a dose of 20 Gy in ten fractions was performed.
Like other pharmacological methods of treatment, radiation therapy could affect bone healing.
A study focused on HO after elbow trauma has shown that single-fraction therapy leads to an
increase risk of non-union [64]. In addition, the location of HO after a total hip arthroplasty is
predictable, whereas that after brain injury is difficult to predict accurately where the ectopic
bone will develop [65]. For this reason, we do not recommend the routine use of radiation
therapy for primary prevention of neurogenic HO, whereas it could be a good method for
secondary prophylaxis.
6.4. Surgery
Surgical resection of established ossifications is the treatment of choice to facilitate rehabilita‐
tion and is the only effective procedure when the ossification is mature.
The surgery is necessary in patients with symptomatic HO and unsuccessful medical treat‐
ment, such as:
• Loss of range of motion and ankylosis with associated functional disability, such as sitting
difficulties
• Complications of immobility such as pressure ulcers
• Facilitate rehabilitation and recovery of muscular atrophy secondary to prolonged immo‐
bilisation
• Difficulties of appropriate hygiene because access to the perineum or bladder care is needed
• Severe pain refractory to analgesia
• Vascular and/or nerve compression
A careful preoperative assessment is mandatory in order to avoid complications. A CT-Scan
is really useful to show intra-articular pathology and the degree of osteoporosis. In addition,
a CT-Scan or MRI with contrast describes the relationship with important neurovascular
structures.
The timing of operative excision is controversial. Some authors recommend timetables for the
best moment to remove these ossifications, but these indications have changed in recent years.
Gartland recommended surgery after six months following traumatic heterotopic ossification,
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one year following spinal cord injury and 18 months after head injury. Another factor to take
into account is the neurological condition of the patient. Severe cognitive and physical
impairment have poor results from surgery with a high rate of recurrence. However, patients
with good neuromuscular control before the surgical procedure have a better functional
outcome [65, 66]. In the past, waiting until maturity in order to minimize the rate of recurrence
after the surgical treatment was recommended. Nevertheless, recent studies do not confirm a
higher rate of recurrence when the HO is excised in an earlier phase [49, 67]. In addition, a long
delay before surgery leads to ankylosis, a high degree of osteoporosis and more extensive intra-
articular injuries. These findings are associated with bad functional results and potential
complications.
Stover et al. [5] showed that the risk of fracture was secondary to osteopenia and this compli‐
cation increased with the delay in surgical treatment. Perioperative fractures are associated
with grade 3 and 4 of osteopenia, according to the classification described by Carlier et al. [43],
so therefore this complication could take into account with a preoperative CT-Scan. In a study
of HO in 183 hips (143 patients), performed by Genet et al. [49], found 25 perioperative fractures
of the femoral neck, all of which occurred in patients with ankylosed hips.
Intra-articular lesions are associated with a smaller range of motion and ankylosis. Some
authors considered it to be neurotrophic arthropathy [68], but more recently Genet et al. [49]
suggested that it is only ankylosis, which induces articular degradation. In addition, these
authors showed that the presence of intra-articular lesions is a cause of worsening of the final
results.
In general, the surgical goal is resection of a large enough amount of bone to allow improve‐
ment of the range of motion and trying to preserve the joint [49, 69]. A good knowledge of the
anatomy is paramount and adequate exposure should be performed with identification of the
relationship with neurovascular structures. Intraoperative neurologic monitoring with use of
electromyography or somatosensory evoked potentials may be useful, especially in the hip.
We use osteotomes and high-speed burrs to remove the ossifications and we frequently use
fluoroscopy to check the bone removal (Figure 3). Intraoperative blood loss can be substantial
so careful bleeding control should be performed and we recommend that local haemostatic
agents should be available, such as bone wax and gelatine-based products. Much of the
bleeding is from the osteotomized bone surfaces and is difficult to control with electrocautery.
Furthermore, meticulous haemostasis and elimination of dead space decrease the risk of
infection.
Wide exposure and identification of major vessels and nerves is extremely important. In many
cases, the ossifications have a close relationship with important neurovascular structures and
there is distortion of the normal anatomy. Therefore, there is a relatively high risk of iatrogenic
injury. Especially in the hip, this complication is extremely important and sometimes life
threatening, so therefore we recommend performing this surgical procedure with the assis‐
tance of a vascular surgeon [69].
There is a significant risk of recurrence and we recommend prophylaxis methods, such as
physical therapy and the administration of indomethacin for two or four weeks. Although no
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data have shown the benefit of radiotherapy or medical treatment when ossifications are
mature, it is reasonable to use prophylactic treatment postoperatively aiming to prevent
recurrence. [66].
7. Conclusion
Heterotopic ossifications after a brain injury present multiple challenges because of the
difficult management of this disease. Although it is difficult to predict the development of
NHO, it is correlated with the severity of brain damage and several risk factors have been
reported. The hip is the most commonly involved joint and the clinical presentation could
mimic a septic arthritis or phlebitis in the early stage (3-12 weeks after the neurological injury).
Later, although the NHO could be asymptomatic, it can lead to limited range of motion and
                                        a)                      b) 
 
                                       c) 
 
 
Figure 3. Heterotopic ossification in the right hip causing severe ankylosis. a) Preoperative imaging showing a huge
HO from the lesser trochanter to the ilium. b) Preoperative CT-Scan showing involvement of the muscles iliopsoas,
vastus medialis and vastus intermedius. b) Radiograph 12 months after surgery.
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ankylosis of the affected joint. Early detection and prevention with physical therapy, NSAIDs
or bisphosphonates have shown good results. Surgery is recommended when the functional
status is affected and thorough preoperative planning should be done to avoid further
complications. Although, there is controversy in deciding the timing of surgery, recent articles
have suggested that early surgical excision decreases the likelihood of developing osteopenia
and intra-articular lesions.
This entity remains a poorly understood condition, so further research in neurogenic hetero‐
topic ossifications should help in continuing to understand pathophysiology, identify path‐
ways and target cells and tissues to find better methods of prevention and treatment.
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